InvestorsHub Logo
Followers 54
Posts 2836
Boards Moderated 0
Alias Born 03/17/2014

Re: Shell Man post# 19867

Wednesday, 09/02/2020 10:17:24 AM

Wednesday, September 02, 2020 10:17:24 AM

Post# of 198661
Agree and according to what the treatment can do will be the key:

We have tested ImmunH on volunteers and the medicine has shown that it is highly effective(for full destruction of the viruses) and is absolutely harmless. ImmunH can also be used to strengthen the immune system in people that are not infected with a virus, because it is a natural product.

We are a corporation, which is dedicated to the development of medicine for HIV-1 Infection, Chronic Infection, Hepatitis(A,B,C), Rheumatoid Arthritis, some types of Cancer and every other viruses connected with the immune system of the human being.

https://www.immunotechlaboratoriesbg.com/


Enzolytics currently holds a 49% Interest in Immunotech Laboratories BG-Europe. Immunotech BG-Europe has a license for the development and commercialization of Enzolytics Patented ITV-1 Technology. Immunotech BG-Europe , under the branded ImmunH , utilizing the technology has successfully completed Phase III clinical trials at the Specialized Hospital for Active Treatment of Infectious and Parasite Disease in Sofia, Bulgaria, specific for the treatment of HIV/AIDS.

ImmunoTech Laboratories BG-Europe has filed for a mass use permit, Phase IV, in Bulgaria. Enzolytics is seeking a Contract Manufacturing Organization (CMO) in the United States to produce the Immunotherapy Treatment to be used as the validation batch in coordination with the Bulgarian regulatory authority and Immunotech BG-Europe.
Additionally, ImmunoTech BG-Europe has informed Enzolytics that they will be seeking to register the ImmunH product as a ImmuneModulator, allowing use as an adjunct in additional applications to regulate or normalize the Immune System.

https://enzolytics.com/immunh-bg%2Feurope

$ENZC
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News